Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

The Oncotype DX Recurrence Score (RS), Prosigna Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) are used clinically for estimating risk of distant recurrence for patients receiving endocrine therapy. Discordances in estimates occ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Buus, Richard, Sestak, Ivana, Kronenwett, Ralf, Ferree, Sean, Schnabel, Catherine A., Baehner, Frederick L., Mallon, Elizabeth A., Cuzick, Jack, Dowsett, Mitch
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2021
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078458/
https://ncbi.nlm.nih.gov/pubmed/33108242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00853
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados